Molecular MD, a 10-year-old Portland diagnostics company, has raised $500,000 out of a $2 million offering, according to a filing with the U.S. Securities and Exchange Commission.
The company has contracts with all the major global pharmaceutical companies and helps bring new drugs through clinical trials and to market. The company works with academic research centers, including Oregon Health & Science University, to license new oncology biomarkers.
MolecularMD does clinical testing on blood and…
Molecular MD, a 10-year-old Portland diagnostics company, has raised $500,000 out of a $2 million offering, according to a filing with the U.S. Securities and Exchange Commission.
The company has contracts with all the major global pharmaceutical companies and helps bring new drugs through clinical trials and to market. The company works with academic research centers, including Oregon Health & Science University, to license new oncology biomarkers.
MolecularMD does clinical testing on blood and…